As of Aug 28
| +0.17 / +0.11%|
The 16 analysts offering 12-month price forecasts for Amgen have a median target of 187.50, with a high estimate of 211.00 and a low estimate of 157.00. The median estimate represents a +20.28% increase from the last price of 155.89.
The current consensus among 20 polled investment analysts is to Buy stock in Amgen. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.